Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
Share:
More In Science
Flu Is on the Rise While RSV Infections May Be Peaking, U.S. Health Officials Say
Flu is picking up steam while RSV lung infections that can hit kids and older people hard may be peaking, U.S. health officials said.
Pharmacies Sued Over Knockoff Weight-Loss Drugs
The maker of Ozempic is suing two pharmacies in Florida for allegedly selling impure versions of the popular weight loss and diabetes management drugs.
Deadly Salmonella Outbreak in Cantaloupe
U.S. officials are urging consumers not to eat cantaloupe products including fruit cups due to a salmonella outbreak.
Countries Donate to Climate Crisis Damage Fund
The 2023 United Nations Climate Change Conference known as COP28 kicked off in Dubai and major progress is already being made.
360 Degree View of Earth
A 360-degree camera was sent into outer space and it collected some remarkable images of Earth.
Study: Penguins Take 4-Second Naps Throughout The Day
A new study published in the journal Science observed chin strap penguins in Antarctica and found that they take thousands of small naps a day each lasting only about four seconds.
Report: Progress in Women's Health Backsliding
A new report reveals that Gen Z and millennial women face many serious issues when it comes to their health.
EPA Pushing to Remove All Lead Pipes Nationwide
EPA Pushing to Remove All Lead Pipes Nationwide
Covid-19 Hospitalizations on the Rise
Covid-19 Hospitalizations on the Rise
